These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14561800)

  • 1. Lessons learned from the management of a rare genetic cancer.
    Cote GJ; Gagel RF
    N Engl J Med; 2003 Oct; 349(16):1566-8. PubMed ID: 14561800
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
    Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
    Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early malignant progression of hereditary medullary thyroid cancer.
    Machens A; Niccoli-Sire P; Hoegel J; Frank-Raue K; van Vroonhoven TJ; Roeher HD; Wahl RA; Lamesch P; Raue F; Conte-Devolx B; Dralle H;
    N Engl J Med; 2003 Oct; 349(16):1517-25. PubMed ID: 14561794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Krampitz GW; Norton JA
    Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medullary carcinoma of thyroid gland].
    Spinelli C; Galleri D; Calbo L; Palmeri R; Miccoli P; Melita P
    Chir Ital; 1997; 49(4-5):21-5. PubMed ID: 10392179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of medullary thyroid carcinoma].
    Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.
    Spinelli C; Di Giacomo M; Costanzo S; Elisei R; Miccoli P
    J Pediatr Surg; 2010 Aug; 45(8):1610-6. PubMed ID: 20713208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
    Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN
    Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.
    Frilling A; Höppner W; Eng C; Mulligan L; Raue F; Broelsch CE
    J Mol Med (Berl); 1995 May; 73(5):229-33. PubMed ID: 7670926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual vignette. Multiple endocrine neoplasia type 2A (MEN2A) associated with cutaneous lichen amyloidosis.
    Bonbassei GJ
    Endocr Pract; 2003; 9(6):570. PubMed ID: 14758805
    [No Abstract]   [Full Text] [Related]  

  • 13. Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A.
    Gibelin H; Bezieau S; Misso C; Bouin-Pineau MH; Maréchaud R; Kraimps JL
    Br J Surg; 2004 Nov; 91(11):1458-9. PubMed ID: 15386323
    [No Abstract]   [Full Text] [Related]  

  • 14. Childhood progression of hereditary medullary thyroid cancer.
    Chabre O; Piolat C; Dyon JF
    N Engl J Med; 2007 Apr; 356(15):1583-4; author reply 1584-5. PubMed ID: 17429094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prophylactic thyroidectomy in children at risk for medullary thyroid carcinoma].
    Torres de Aguirre A; Martínez Carol A; Cabello Laureano R; García Valles C; Gómez Gila A; del Valle Núñez J
    Cir Pediatr; 2005 Jul; 18(3):106-8. PubMed ID: 16209369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 2.
    Forster-Gibson CJ; Mulligan LM
    Eur J Cancer; 1994; 30A(13):1969-74. PubMed ID: 7734209
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
    Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
    Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
    Heshmati HM; Hofbauer LC
    Eur J Endocrinol; 1997 Dec; 137(6):572-8. PubMed ID: 9437218
    [No Abstract]   [Full Text] [Related]  

  • 20. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
    Sasaki Y; Shimotake T; Go S; Iwai N
    Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.